|
|||||
|
|
| 万古霉素治疗NICU获得性肺炎的临床评估 | |
| 引用本文： | 吕元红,周雀云,李秀红,刘晓红. 万古霉素治疗NICU获得性肺炎的临床评估[J]. 中国优生与遗传杂志, 2004, 12(4): 95-96 |
| 作者姓名： | 吕元红 周雀云 李秀红 刘晓红 |
| 作者单位： | 深圳市儿童医院新生儿科,518026 |
| 摘 要： | 目的评价万古霉素治疗NICU获得性细菌性肺炎的临床疗效和安全性.方法随机将42例新生儿获得性肺炎分为治疗组(万古霉素)和对照组,观察万古霉素治疗过程中的临床反应.结果万古霉素治疗新生儿获得性葡萄球菌肺炎的总有效率为88%,明显高于对照组(50%),不良反应较少.结论万古霉素治疗新生儿获得性葡萄球菌肺炎疗效肯定,安全可靠. |
| 关 键 词： | 万古霉素 治疗 新生儿肺炎 不良反应 |
| 文章编号： | 1006-9534(2004)04-0095-02 |
| 修稿时间： | 2003-08-21 |
Clinical evaluation of vancomycin in treatment of neonatal inection pneumonia in NICU |
|
| LU Yuan-hong,ZHOU Que-yun,LI Xiu-hong,et al.. Clinical evaluation of vancomycin in treatment of neonatal inection pneumonia in NICU[J]. Chinese Journal of Birth Health & Heredity, 2004, 12(4): 95-96 | |
| Authors: | LU Yuan-hong ZHOU Que-yun LI Xiu-hong et al. |
| Abstract: | Objective: To investigate clinical therapeutical effect and safety of vancomycin in treatment of neonatal infection pneumonia in NICU. Methods: 42cases, who were ill with infections pneumonia, were randomly divided treated group(vancomycin) and controlled group(third generation cephalosporin) Results: The total effective rate of vancomycin in treatment of neonatal infectious pneumonia in NICU due to staphylococci was 88%, which was obviows higher than the controlled group. The adverse reactions in the treated group was few. Conclusion: The therapeutical effect of vancomycin in treatment of neonatal with staphylococcal pneumonia is definite and safe. |
| Keywords: | Vancomycin Treatment Pneumonia Neonate |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |